Exploring the Link Between Breast Density and Cardiovascular Risk

Innovative research has highlighted the importance of breast density as a potential marker for cardiovascular health, linking it to coronary artery disease (CAD) and broader cardiometabolic risks. As mammography is widely used for breast cancer screening, its potential to assess cardiovascular risk factors presents an opportunity to enhance preventive care for women. Exploring the association between breast density, epicardial adipose tissue volume (EATv) and CAD offers valuable insights into how routine mammographic analysis could serve as a dual-purpose tool for improving health outcomes.

Breast Density and Its Cardiometabolic Implications

Breast density, as measured through mammography, reflects the proportion of fibroglandular tissue relative to fatty tissue in the breast. Dense breasts, with a higher fibroglandular composition, have long been associated with breast cancer risks. However, growing evidence suggests that lower breast density—indicative of increased breast adiposity—may signal heightened vulnerability to cardiometabolic diseases, including CAD.

In a recent study, women with lower breast density demonstrated significantly higher rates of obesity, hypertension and postmenopausal status compared to those with denser breast tissue. These factors, well-documented risk contributors to cardiovascular disease, highlight the systemic nature of low breast density as a marker. In particular, adipose tissue in the breast, akin to visceral fat, secretes pro-inflammatory substances that may exacerbate atherosclerosis.

This connection between breast adiposity and cardiovascular health aligns with findings in other fat deposits, such as epicardial adipose tissue (EAT). Breast density, then, offers a promising avenue for identifying women at greater cardiovascular risk, especially as part of routine health assessments. Unlike other measures, such as waist circumference, which can be prone to inaccuracies, breast density evaluation via mammography provides a precise, reproducible and accessible marker of adiposity.

Epicardial Adipose Tissue Volume: A Critical Factor

Epicardial adipose tissue, the fat surrounding the heart within the pericardium, plays a pivotal role in cardiometabolic health. EAT is a recognised reservoir of pro-inflammatory cytokines, which contribute to the development and progression of coronary plaque, a key factor in CAD. The study revealed a strong correlation between low breast density and increased EATv, highlighting the interconnectedness of adipose tissue deposits in the body.

Women with lower breast density were found to have significantly higher EATv levels, which in turn were associated with greater CAD prevalence. Despite this relationship, the study indicated that the link between breast density and CAD persisted independently of EATv. This suggests that while EATv is a critical mediator of cardiovascular risk, breast density itself may serve as a standalone marker for CAD.

The implications of these findings are profound. EATv has been extensively studied as an imaging biomarker for cardiometabolic health, yet its assessment requires advanced imaging techniques such as coronary computed tomography angiography (CCTA). These methods, though precise, are costly and expose patients to ionising radiation, making them less feasible for routine screening. In contrast, breast density analysis through mammography, a widely adopted and safe diagnostic tool, offers a more straightforward and less invasive alternative for risk stratification.

Mammography's Role in Cardiovascular Screening and Future Considerations

Integrating cardiovascular risk assessment into mammographic screenings has the potential to revolutionise preventive health care for women. Mammography is already an established tool for breast cancer detection, reaching millions annually. By extending its application to evaluate cardiovascular risk factors such as breast density, healthcare providers could identify at-risk individuals earlier and enable timely interventions. Traditional cardiovascular risk calculators often underestimate CAD risk in women, mainly due to gender-specific differences in symptomatology and risk profiles. Incorporating breast density measurements into risk assessments could help bridge this gap, particularly for postmenopausal women who exhibit lower breast density and higher rates of CAD.

Breast density is also a modifiable parameter influenced by lifestyle factors such as diet, exercise and weight management. Reducing overall body fat has been shown to increase breast density, providing an actionable pathway for mitigating cardiovascular risk. Furthermore, breast arterial calcifications—another feature detectable through mammography—have shown potential as indicators of cardiovascular health. When combined with breast density analysis, these findings enhance mammography’s predictive value for CAD risk, maximising the utility of existing resources while empowering women to manage their health proactively.

Despite its promise, using breast density as a cardiovascular risk marker requires further validation. The retrospective design of recent studies raises concerns about selection bias, as participants often undergo imaging for clinical indications. Larger, prospective studies are necessary to confirm the generalisability of findings to broader populations. Additionally, breast density must be interpreted alongside other factors such as age, menopausal status and hormonal influences, which affect its relationship with cardiovascular risk. For instance, while low breast density correlates with CAD, the association persists even after adjusting for age, indicating the need for nuanced interpretation within a comprehensive risk assessment framework.

The practical implementation also presents challenges. Training radiologists to interpret breast density in the context of cardiovascular health, integrating findings into electronic health records and coordinating cross-disciplinary efforts would be essential. Public health campaigns could raise awareness about the link between breast density and cardiovascular risk, encouraging women to take proactive steps in managing their heart health. Together, these efforts could transform mammography into a dual-purpose tool for improving outcomes in women’s health.

The relationship between breast density, EATv and CAD underscores the potential of mammography as a dual-purpose tool for health screening. By incorporating cardiovascular risk assessment into existing breast cancer screening programmes, healthcare systems can provide more comprehensive care for women, addressing two leading causes of morbidity and mortality. While further research is needed to refine these associations and develop standardised guidelines, the integration of breast density analysis into routine practice represents a significant step forward in preventive health care. As awareness of these findings grows, women will be better equipped to take charge of their cardiovascular and overall health, paving the way for improved outcomes and quality of life.

Source: Clinical Imaging

Image Credit: iStock